Fellowbook News

Tiny killers: How autoantibodies attack the heart in lupus patients

Columbia team engineers a model of the human heart tissue that demonstrates how autoantibodies directly affect heart disease in lupus patients

Cardiovascular disease is the leading cause of death in patients suffering from lupus, an autoimmune disease in which our immune system attacks our own tissues and organs, the heart, blood, lung, joints, brain, and skin. Lupus myocarditis–inflammation of the heart muscle– can be very serious because the inflammation alters the regularity of the rhythm and strength of the heartbeat. However, the mechanisms underlying this complex disease are poorly understood and difficult to study.

A long-standing question about lupus is why some patients develop myocarditis while others remain unaffected. And why the clinical manifestations of affected patients range so dramatically, from no symptoms at all to severe heart failure. Lupus is characterized by a large number of autoantibodies, immune proteins that mistakenly target a person’s own tissues or organs, with different specificities for various molecules. Like our genes, they may explain why different individuals experience different symptoms… Continue reading.

Why inflammation persists in cystic fibrosis—even after CFTR correction
Chronic lung inflammation in cystic fibrosis (CF) often persists even after treatment with newly-approved gene therapies or small molecule CFTR modulators—an unresolved clinical paradox. A new study published in EXO – Beyond the Cell identifies...
A lung-mimicking sealant helps repair surgical leaks
A superior surgical sealant mimics the structural and mechanical properties of lung tissue to repair air leaks after surgery. A new sealant meant to mimic lung tissue has been shown to rapidly cork air leaks following surgery. Moreover, the protein-like...
Tissue chip developments: what’s the 411?
Tissue chips—tiny mimics of human organs, just millimeters in size—represent an alternative to animal models as a way to study disease or evaluate drugs. However, a major limitation of tissue chips is that they do not faithfully imitate tissue interactions,...
Plug-and-play organ-on-a-chip can be customized to the patient
Engineered tissues have become a critical component for modeling diseases and testing the efficacy and safety of drugs in a human context. A major challenge for researchers has been how to model body functions and systemic diseases with multiple engineered...
Gordana Vunjak-Novakovic Receives AIMBE’s Highest Award
AIMBE is honored to recognize Gordana Vunjak-Novakovic with its Pierre Galletti Award, the Institute’s highest accolade. Including years of contributions to AIMBE and the BME community, Vunjak-Novakovic is recognized for impactful innovations in technologies...